MEDIA
Want to find out what’s happening with us?
Here’s the latest buzz…
JULY, 2024
Exciting Update @ Somerset, 6 New Products Launched in record time
It’s been an eventful couple of weeks at Somerset, marked by the successful launch of 6 new products in rapid succession. The first launch was Cupric Chloride for which we received CGT status and will be among one of the few companies offering the generic in the market. Alongside this milestone, we have successfully introduced Acetylcysteine Injection USP, Midazolam Injection USP, Hydroxyurea Capsules, Timolol Maleate OS and Potassium Phosphate.
“The launch of six new products in quick succession demonstrates our commitment to research and development, as well as our dedication to maintaining a robust product pipeline. This consistent effort ensures that we can offer a portfolio that meets the industry’s demand for high-quality generic suppliers.”
– Dr. Veerappan Subramanian
Chairman & CEO, Somerset Pharma
We extend our heartfelt thanks to our healthcare partners for their unwavering support and faith in the company. Together, we look forward to reaching new heights and celebrating many more achievements in the future.